These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3057327)

  • 1. Vancomycin ototoxicity and nephrotoxicity. A review.
    Bailie GR; Neal D
    Med Toxicol Adverse Drug Exp; 1988; 3(5):376-86. PubMed ID: 3057327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.
    Elting LS; Rubenstein EB; Kurtin D; Rolston KV; Fangtang J; Martin CG; Raad II; Whimbey EE; Manzullo E; Bodey GP
    Cancer; 1998 Dec; 83(12):2597-607. PubMed ID: 9874468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.
    Bhatt-Mehta V; Schumacher RE; Faix RG; Leady M; Brenner T
    Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycopeptides and the newborn infant's kidney].
    Fanos V; Benini D; Vinco S; Pizzini C; Khoory BJ
    Pediatr Med Chir; 1997; 19(4):259-62. PubMed ID: 9508651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vancomycin concentrations: reappraisal of their clinical value.
    Cantú TG; Yamanaka-Yuen NA; Lietman PS
    Clin Infect Dis; 1994 Apr; 18(4):533-43. PubMed ID: 8038306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
    Rostas SE; Kubiak DW; Calderwood MS
    Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
    Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
    Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity and Nephrotoxicity With Elevated Serum Concentrations Following Vancomycin Overdose: A Retrospective Case Series.
    Uda K; Suwa J; Ito K; Hataya H; Horikoshi Y
    J Pediatr Pharmacol Ther; 2019; 24(5):450-455. PubMed ID: 31598110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.
    Cimino MA; Rotstein C; Slaughter RL; Emrich LJ
    Am J Med; 1987 Dec; 83(6):1091-7. PubMed ID: 3503577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
    Kralovicová K; Spanik S; Halko J; Netriova J; Studena-Mrazova M; Novotny J; Grausova S; Koren P; Krupova I; Demitrovicova A; Kukuckova E; Krcmery V
    J Chemother; 1997 Dec; 9(6):420-6. PubMed ID: 9491842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin nephrotoxicity: a review.
    Mergenhagen KA; Borton AR
    J Pharm Pract; 2014 Dec; 27(6):545-53. PubMed ID: 25266809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxic and nephrotoxic drugs in neonatal intensive care units: results of a Spanish and Italian survey.
    Arribas C; Decembrino N; Raffaeli G; Amodeo I; González-Caballero JL; Riaza M; Ortiz-Movilla R; Massenzi L; Gizzi C; Araimo G; Cattarelli D; Aversa S; Martinelli S; Frezza S; Orfeo L; Mosca F; Cavallaro G; Garrido F;
    Eur J Pediatr; 2024 Jun; 183(6):2625-2636. PubMed ID: 38492032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
    Nahata MC
    Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.
    Darko W; Medicis JJ; Smith A; Guharoy R; Lehmann DE
    Pharmacotherapy; 2003 May; 23(5):643-50. PubMed ID: 12741439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term vancomycin use had low risk of ototoxicity.
    Humphrey C; Veve MP; Walker B; Shorman MA
    PLoS One; 2019; 14(11):e0224561. PubMed ID: 31693679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.